Abstract
Cervical cancer remains one of the most important social and medical problems worldwide due to the increase in morbidity and mortality. Improvement of existing and development of new options for diagnosis and treatment of common stages of cervical cancer is an urgent problem of modern Oncology. In accordance with the standards of treatment for advanced cervical cancer, drug, radiation therapy and surgical treatment in various modifications are used. Neoadjuvant chemotherapy can reduce the volume of tumors, which helps to achieve optimal resectability of the tumors, increases the ablasticity of the operation. In addition, it improves survival. An accurate assessment of the effectiveness of treatment is one of the important factors in the overall treatment. Complex ultrasound diagnostics is the most affordable and common imaging method, possessing a number of important technologies, allowing you to get the most objectively visualized tumors, uterus, prevalence, blood flow features and to receive timely information about tumor regression. In connection with the introduction of new technologies, a significant expansion of the capabilities of ultrasound diagnostics in oncology as a whole is observed today. The most promising of them are ultrasound elastography and contrast-enhanced ultrasound. The review is devoted to the possibilities of these methods in assessing the effectiveness of neoadjuvant chemotherapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
